You are here: Industry Insights > Treatment

News List

High-dose Erythropoietin No Benefit for Extreme Preemies drugs
January 20, 2020
For extremely preterm infants, high-dose erythropoietin treatment from 24 hours after birth does not result in a reduced risk for severe neurodevelopmental impairment or death at age 2 years ...
SinuSonic Clinical Trial Data Shows Safety and Efficacy for Nonpharmacologic Device americanpharmaceuticalreview
December 30, 2019
Healthy Humming has announced positive topline data from a prospective outcomes study, which assessed the safety and efficacy of the SinuSonic ...
Survival Up for Chronic Lymphocytic Leukemia 1995 to 2017 drugs
December 27, 2019
For patients with chronic lymphocytic leukemia (CLL) in routine care, overall survival improved from 1995 to 2017, according to a study recently published in Leukemia & Lymphoma.
Factors Predict Adverse Opioid-Related Outcomes in Cancer Survivors drugs
December 26, 2019
Among cancer survivors, demographic, cancer, and treatment factors can predict adverse opioid-related outcomes, according to a study published online in the Journal of the National Cancer Institute.
Apollo Hospitals' Unique Initiative to Provide Best Treatment Plan for Cancer Patients En-CPhI.CN
October 23, 2019
Cancer is the second leading cause of death globally and was responsible for over 9.6 million deaths in 2018 alone.
Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial En-CPhI.CN
October 11, 2019
Datar Cancer Genetics, a cancer research company, today announced positive data from the phase II/III RESILIENT trial intended to validate clinical benefit for cancer patients ...
Prostate Cancer Risk Higher in Men Receiving Fertility Treatment drugs
September 27, 2019
Men fathering children through assisted reproduction techniques rather than natural conception have an increased risk for prostate cancer, including early-onset disease, according to a study published online in The BMJ.
FDA Statement on Final Guidance to Advance ALS Treatments americanpharmaceuticalreview
September 25, 2019
By Norman E. "Ned" Sharpless M.D., Acting Commissioner of Food and Drugs, Janet Woodcock M.D., Director - Center for Drug Evaluation and Research ...
First oral GLP-1 treatment for type 2 diabetes approved europeanpharmaceuticalreview
September 24, 2019
With the approval of the treatment, Rybelsus, there is a new option for treating type 2 diabetes without injections.
Hereditary angioedema treatment recommended by NICE europeanpharmaceuticalreview
September 20, 2019
Lanadelumab, a preventive treatment for hereditary angioedema, has been recommended as a cost-effective use of NHS resources.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page